CCR8 antagonist 2
Modify Date: 2024-01-09 17:42:36
CCR8 antagonist 2 structure
|
Common Name | CCR8 antagonist 2 | ||
|---|---|---|---|---|
| CAS Number | 2756350-98-6 | Molecular Weight | 464.02 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H30ClN3O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CCR8 antagonist 2CCR8 antagonist 2 is a potent antagonist of CCR8. CCR8 (C-C Motif Chemokine Receptor 8) is predominantly expressed on Treg cells and Th2 cells, but not on Th1 cells. CCR8 antagonist 2 inhibits CCR8 activity, which may be used in the treatment of diseases mediated by CCR8, such as cancer, and/or neuropathic pain (extracted from patent WO2022000443A1, compound 220)[1]. |
| Name | CCR8 antagonist 2 |
|---|
| Description | CCR8 antagonist 2 is a potent antagonist of CCR8. CCR8 (C-C Motif Chemokine Receptor 8) is predominantly expressed on Treg cells and Th2 cells, but not on Th1 cells. CCR8 antagonist 2 inhibits CCR8 activity, which may be used in the treatment of diseases mediated by CCR8, such as cancer, and/or neuropathic pain (extracted from patent WO2022000443A1, compound 220)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Guohuang FAN, et al. Methods and compositions for targeting tregs using ccr8 inhibitors. |
| Molecular Formula | C23H30ClN3O3S |
|---|---|
| Molecular Weight | 464.02 |